Case report: Short-term eculizumab use in atypical HUS associated with Lemierre's syndrome and post-infectious glomerulonephritis

Atypical hemolytic uremic syndrome (aHUS) is a rare disease caused by genetic abnormalities, infections, autoimmune diseases, drugs, and malignancies. Anti-C5 monoclonal antibody eculizumab is the mainstay of treatment of aHUS caused by the genetic defects of the alternative complement pathway. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Sadiq, Sanober, Urisman, Anatoly, Cil, Onur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189804/
https://www.ncbi.nlm.nih.gov/pubmed/37206472
http://dx.doi.org/10.3389/fmed.2023.1167806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189804/
https://www.ncbi.nlm.nih.gov/pubmed/37206472
http://dx.doi.org/10.3389/fmed.2023.1167806

Ejemplares similares